SEC Filings for Proteostasis Therapeutics Inc. (PTI)

$ 1.44   0.06 (+4.35%) Volume: 1.88m 4:00 PM EDT Jun 4, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
3Initial statement of beneficial ownership of securities205/15/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)7505/15/2020
8-KCurrent report pursuant to Section 13 or 15(d)805/15/2020
DEF 14AOther definitive proxy statements3804/29/2020
DEFA14AAdditional proxy soliciting materials - definitive204/29/2020
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans603/13/2020
10-KAnnual report pursuant to Section 13 or 15(d)28303/10/2020
8-KCurrent report pursuant to Section 13 or 15(d)803/10/2020
8-KCurrent report pursuant to Section 13 or 15(d)2203/05/2020
4Statement of changes in beneficial ownership of securities103/04/2020
4Statement of changes in beneficial ownership of securities103/04/2020
4Statement of changes in beneficial ownership of securities103/04/2020
4Statement of changes in beneficial ownership of securities103/04/2020
4Statement of changes in beneficial ownership of securities103/04/2020
4Statement of changes in beneficial ownership of securities103/04/2020
<<
First
<
Prev
123456789101112131415